RICT Strasbourg July 4-6, 2018

NovAliX is a drug discovery-focused CRO with several unique technologies. It is highly proficient in chemistry and biophysics. Our commitment and reliability are much appreciated by a worldwide client base.


Our chemistry platform includes custom synthesis, library enrichment and focused library generation.
NovAliX offers a unique chemical Small Molecule Mircoarray SPR screening – High Throughput platform. Library of 116,000 including 25,000 fragments and a comprehensive NMR screen of plant derived fragments.NovAliX capabilities incorporates a comprehensive Drug Discovery offer.


Visit us at Booth #16th!